Merkel cell carcinoma

Active Research Protocols

  1. 13-C-0173 – Phase II Open-Label Trial of Ipilimumab for Metastatic Merkel Cell Carcinoma
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014